Fintel reports that on January 21, 2026, B of A Securities upgraded their outlook for Apellis Pharmaceuticals (NasdaqGS:APLS) from Neutral to Buy. Analyst Price Forecast Suggests 76.24% Upside As of ...
Q4 2025 earnings call insights: record EPS/revenue, strong NIM and credit, plus 2026 loan/deposit growth guidance.
Q4 2025 Earnings Call Transcript January 20, 2026 BOK Financial Corporation beats earnings expectations. Reported EPS is ...
Chicago-based Choreo has agreed to acquire substantially all assets of two Pennsylvania RIAs with a combined $1.3 billion in ...
Industry veteran and respected licensed health insurance producer joins one of the nation's largest FMOs to scale an ...
A Manitoba junior hockey team is getting an off-ice lesson in money management through a new partnership with University ...
Raymond James is set to broaden its asset management reach with an agreement to acquire Clark Capital Management Group, a ...
To succeed in the competitive Canadian prairies, you need more than just a good product. You also need a strong financial ...
Q4 2025 Earnings Call January 21, 2026 8:30 AM ESTCompany ParticipantsLisa Hajdu - Manager of Investor RelationsVincent J.
The AFA will detail the financial engineering and the fee corresponding to each club for their participation in the Primera ...
W1M Wealth Management has bought independent wealth and investment management partnership Vermeer Partners. The deal, which ...
One of two men sentenced in a Hartford mortgage fraud scheme had his sentence commuted by President Donald Trump.